Skip to main content
. 2023 Apr 29;3(1):e149. doi: 10.52225/narra.v3i1.149

Table 4. Antimicrobial-susceptibility pattern of Gram-positive isolates to different antibiotics.

Antibiotics Staphylococcus aureus (n=10) Staphylococcus haemolyticus (n=6) Staphylococcus epidermidis (n=2)
n (%) n (%) n (%)
Amoxicillin/clavulanic acid 5 (50.0) * 6 (100.0) ‡ 2 (100.0) ‡
Amoxicillin 1 (10.0) * 6 (100.0) ‡ 2 (100.0) ‡
Azithromycin 10 (100.0) *** 6 (100.0) ‡ 2 (100.0) ***
Cefixime 5/5 (100.0) ‡ 6 (100.0) ‡ 2 (100.0) ‡
Cefoperazone 5 (50.0) * 6 (100.0) ‡ 2 (100.0) ‡
Ciprofloxacin 5 (50.0) * 6 (100.0) ‡ 2 (100.0) ‡
Clarithromycin 10 (100.0) *** 6 (100.0) ‡ 2 (100.0) ***
Clindamycin 10 (100.0) *** 2 (33.3) * 2 (100.0) ‡
Ceftriaxone 5 (50.0) * 6 (100.0) ‡ 2 (100.0) ‡
Cefotaxime 5 (50.0) * 6 (100.0) ‡ 2 (100.0) ‡
Ceftizoxime 5 (50.0) * 6 (100.0) ‡ 2 (100.0) ‡
Doxycycline 7/7 (100.0) *** - 2 (100.0) ***
Erythromycin 10 (100.0) *** 6 (100.0) ‡ 2 (100.0) ***
Cefepime 5 (50.0) * 6 (100.0) ‡ 2 (100.0) ‡
Cefoxitin 1/6 (17.0) * 6 (100.0) ‡ 2 (100.0) ‡
Nitrofurantoin 10 (100.0) *** 6 (100.0) ‡ 2 (100.0) ***
Imipenem 5 (50.0) * 6 (100.0) ‡ 2 (100.0) ‡
Levofloxacin 5 (50.0) * 6 (100.0) ‡ 2 (100.0) ‡
Linezolid 10 (100.0) *** 6 (100.0) *** 2 (100.0) ***
Methicillin 5 (50.0) * 6 (100.0) ‡ 2 (100.0) ‡
Meropenem 5 (50.0) * 6 (100.0) ‡ 2 (100.0) ‡
Oxacillin 5 (50.0) * 6 (100.0) ‡ 2 (100.0) ***
Piperacillin 1 (10.00) * 6 (100.0) ‡ 2 (100.0) ‡
Rifampicin 10 (100.0) *** 3 (50.0) * 2 (100.0) ***
Ampicillin/sulbactam 5 (50.0) * 6 (100.0) ‡ 2 (100.0) ‡
Tigecycline 10 (100.0) *** 5/5 (100.0) *** 2 (100.0) ***
 Ticarcillin 1 (10.0) * 6 (100.0) ‡ 2 (100.0) ‡
Piperacillin/tazobactam 5 (50.0) * 6 (100.0) ‡ 2 (100.0) ‡
Vancomycin 10 (100) *** 5 (83.3) ** 2 (100.0) ***

‡ Resistant

*<70% of isolates are susceptible

** 70–90% of isolates are susceptible

*** ≥ 90% of isolates are susceptible

-Intrinsic resistance